FDA Drug Safety Information for December 26, 2023

Dec 262023
 

Date Brand Name(s) Description Type Reason Company  26-Dec-2023 Hospira 4.2% Sodium bicarbonate injection, 8.4% Sodium bicarbonate injection, Atropine sulfate injection Drugs Presence of Glass Particulate

FDA Drug Safety Information for December 22, 2023

Dec 222023
 

Date Brand Name(s) Description Type Reason Company  22-Dec-2023 Americaine Benzocaine Topical Anesthetic Spray Drugs Presence of benzene Insight Pharmaceuticals 22-Dec-2023 No Brand Bleomycin for Injection,

FDA Drug Safety Information for December 21, 2023

Dec 212023
 

Date Brand Name(s) Description Type Reason Company  21-Dec-2023 ResMed Masks with magnets Medical Devices Potential for magnetic interference near certain implants and medical devices ResMed

FDA Novel Drug Approvals – November 2023

Dec 012023
 

Drug Name Active Ingredient(s) Approval Date FDA-Approved Use on Approval Date Press Release Drug Trials Snapshot Ogsiveo nirogacestat 11/27/2023 To treat adults with progressing desmoid

FDA Drug Safety Information for November 27, 2023

Nov 272023
 

Date Brand Name(s) Description Type Reason Company  27-Nov-2023 Novartis Sandimmune (cyclosporine oral solution, USP) Oral Solution 100 mg/mL Drugs Due to crystallization formation Novartis Pharmaceuticals

 Older Entries  Newer Entries